Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 2,670.00
+65.00 (2.50%)
At close: Aug 4, 2025, 3:30 PM KST
2.50% (1Y)
| Market Cap | 81.29B |
| Revenue (ttm) | 29.84B |
| Net Income (ttm) | -19.04B |
| Shares Out | 31.09M |
| EPS (ttm) | -619.34 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 70,717 |
| Average Volume | 179,601 |
| Open | 2,540.00 |
| Previous Close | 2,605.00 |
| Day's Range | 2,540.00 - 2,750.00 |
| 52-Week Range | 2,170.00 - 5,870.00 |
| Beta | 1.13 |
| RSI | 39.44 |
| Earnings Date | Aug 14, 2025 |